BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 31389121)

  • 1. MicroRNA-132-3p inhibits tumor malignant progression by regulating lysosomal-associated protein transmembrane 4 beta in breast cancer.
    Li S; Xu JJ; Zhang QY
    Cancer Sci; 2019 Oct; 110(10):3098-3109. PubMed ID: 31389121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LAPTM4B Predicts Axillary Lymph Node Metastasis in Breast Cancer and Promotes Breast Cancer Cell Aggressiveness in Vitro.
    Xiao M; Yang S; Meng F; Qin Y; Yang Y; Jia S; Cai X; Li C; Huang Y; Ning X
    Cell Physiol Biochem; 2017; 41(3):1072-1082. PubMed ID: 28245476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-520c-3p negatively regulates EMT by targeting IL-8 to suppress the invasion and migration of breast cancer.
    Tang CP; Zhou HJ; Qin J; Luo Y; Zhang T
    Oncol Rep; 2017 Nov; 38(5):3144-3152. PubMed ID: 29048659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-372-3p promotes the epithelial-mesenchymal transition in breast carcinoma by activating the Wnt pathway.
    Fan X; Huang X; Li Z; Ma X
    J BUON; 2018; 23(5):1309-1315. PubMed ID: 30570852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and β-catenin pathway in Hepatocellular Carcinoma.
    Wu G; Zheng K; Xia S; Wang Y; Meng X; Qin X; Cheng Y
    J Exp Clin Cancer Res; 2016 Jun; 35(1):89. PubMed ID: 27259866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-409-3p regulates cell invasion and metastasis by targeting ZEB1 in breast cancer.
    Ma Z; Li Y; Xu J; Ren Q; Yao J; Tian X
    IUBMB Life; 2016 May; 68(5):394-402. PubMed ID: 27079864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-410 Acts as a Tumor Suppressor in Estrogen Receptor-Positive Breast Cancer Cells by Directly Targeting ERLIN2 via the ERS Pathway.
    Wu H; Li J; Guo E; Luo S; Wang G
    Cell Physiol Biochem; 2018; 48(2):461-474. PubMed ID: 30016800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-181b-3p promotes epithelial-mesenchymal transition in breast cancer cells through Snail stabilization by directly targeting YWHAG.
    Yoo JO; Kwak SY; An HJ; Bae IH; Park MJ; Han YH
    Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1601-11. PubMed ID: 27102539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Transcription Factor AP4 Promotes Oncogenic Phenotypes and Cisplatin Resistance by Regulating
    Wang L; Meng Y; Xu JJ; Zhang QY
    Mol Cancer Res; 2018 May; 16(5):857-868. PubMed ID: 29378908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-188-5p inhibits tumour growth and metastasis in prostate cancer by repressing LAPTM4B expression.
    Zhang H; Qi S; Zhang T; Wang A; Liu R; Guo J; Wang Y; Xu Y
    Oncotarget; 2015 Mar; 6(8):6092-104. PubMed ID: 25714029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-promoting properties of miR-8084 in breast cancer through enhancing proliferation, suppressing apoptosis and inducing epithelial-mesenchymal transition.
    Gao Y; Ma H; Gao C; Lv Y; Chen X; Xu R; Sun M; Liu X; Lu X; Pei X; Li P
    J Transl Med; 2018 Feb; 16(1):38. PubMed ID: 29471858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2.
    Ma P; Ni K; Ke J; Zhang W; Feng Y; Mao Q
    Exp Biol Med (Maywood); 2018 Mar; 243(5):473-480. PubMed ID: 29368542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
    Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z
    J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-510 promotes cell and tumor growth by targeting peroxiredoxin1 in breast cancer.
    Guo QJ; Mills JN; Bandurraga SG; Nogueira LM; Mason NJ; Camp ER; Larue AC; Turner DP; Findlay VJ
    Breast Cancer Res; 2013; 15(4):R70. PubMed ID: 23971998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
    Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
    Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA-sequence-based microRNA expression signature in breast cancer: tumor-suppressive miR-101-5p regulates molecular pathogenesis.
    Toda H; Seki N; Kurozumi S; Shinden Y; Yamada Y; Nohata N; Moriya S; Idichi T; Maemura K; Fujii T; Horiguchi J; Kijima Y; Natsugoe S
    Mol Oncol; 2020 Feb; 14(2):426-446. PubMed ID: 31755218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-1236-3p inhibits proliferation and invasion of breast cancer cells by targeting ZEB1.
    Liang TC; Fu WG; Zhong YS
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9988-9995. PubMed ID: 31799668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutamate metabotropic receptor 4 (GRM4) inhibits cell proliferation, migration and invasion in breast cancer and is regulated by miR-328-3p and miR-370-3p.
    Xiao B; Chen D; Zhou Q; Hang J; Zhang W; Kuang Z; Sun Z; Li L
    BMC Cancer; 2019 Sep; 19(1):891. PubMed ID: 31492116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY; Xue M; Zhang QC; Su CF
    Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.
    Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M
    Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.